Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Meyer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Psychiatry|December 18, 2018
The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in MiceNurulain T Zaveri, Paul V Marquez, Michael E Meyer, et al.
Alcoholism, Clinical and Experimental Research|December 8, 2017
A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in MiceNurulain T Zaveri, Paul V Marquez, Michael E Meyer, et al.
Journal of Medicinal Chemistry|January 18, 2020
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease ModelsUma Gayathri Kamakolanu, Michael E Meyer, Dennis Yasuda, et al.
British Journal of Pharmacology|December 13, 2017
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsLudovico Arcuri, Salvatore Novello, Martina Frassineti, et al.
European Journal of Pharmacology|November 6, 2016
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Maria Camilla Cerlesi, Davide Malfacini, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Psychiatry|December 18, 2018
The Nociceptin Receptor (NOP) Agonist AT-312 Blocks Acquisition of Morphine- and Cocaine-Induced Conditioned Place Preference in MiceNurulain T Zaveri, Paul V Marquez, Michael E Meyer, et al.
Alcoholism, Clinical and Experimental Research|December 8, 2017
A Novel and Selective Nociceptin Receptor (NOP) Agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) Decreases Acquisition of Ethanol-Induced Conditioned Place Preference in MiceNurulain T Zaveri, Paul V Marquez, Michael E Meyer, et al.
Journal of Medicinal Chemistry|January 18, 2020
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease ModelsUma Gayathri Kamakolanu, Michael E Meyer, Dennis Yasuda, et al.
British Journal of Pharmacology|December 13, 2017
Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonistsLudovico Arcuri, Salvatore Novello, Martina Frassineti, et al.
European Journal of Pharmacology|November 6, 2016
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparationsFederica Ferrari, Maria Camilla Cerlesi, Davide Malfacini, et al.
Pageof 2